Drug
N-carbamylglutamate
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(2)
Other(1)
Detailed Status
Terminated1
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
terminated133%
unknown133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_2
N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
NCT00843921
terminatedphase_2
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
NCT01597440
withdrawnphase_2
Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate
NCT01341379
Clinical Trials (3)
Showing 3 of 3 trials
NCT00843921Phase 2
N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
NCT01597440Phase 2
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
NCT01341379Phase 2
Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3